The U.S. Food and Drug Administration on Friday recommended wider approval of Roche Holding eye drug, Lucentis. An estimated 75,000 new cases of diabetic macular edema develop each year in the U.S.
Read more
FDA Approves Lucentis for Diabetic Eye Disorder
Posted in Drugs